Smoking cessation drug linked to birth defects when taken during pregnancy
Research has linked Zyban (Bupropion) to an increased risk of life-threatening, congenital, cardiac birth defects in babies born to mothers who took the drug(s) during pregnancy. Zyban is marketed as a prescription smoking cessation drug. The drug is also approved for the treatment of depression under the brand name Wellbutrin.
PHOENIX, July 7, 2015 /PRNewswire/ -- The Arentz Law Group is currently investigating cases of birth defects caused by the stop-smoking drug Zyban. Women who have taken Zyban while pregnant, and given birth to a child born with a birth defect, are encouraged to contact the law firm immediately for a free legal consultation.
An article recently published in the American Journal of Obstetrics & Gynecology showed that mothers who took Zyban during pregnancy had an increased risk of giving birth to a child with "left outflow tract heart defects". Left outflow tract heart defects affect the flow of blood from the heart's left chambers to the rest of the body. In this study, the most common type of this defect was coarctation of the aorta -- a narrowing in the body's main artery that, in children, typically requires surgical repair.
The experienced birth defect lawyers of the Arentz Law Group are now investigating the link between Zyban and left outflow tract heart defects, and are accepting Zyban Birth Defect Cases in all 50 states.
Women who have taken Zyban or Wellbutrin (Brupropion), and have given birth to a child with birth defects, can call 1-800-305-6000 or visit arentzlaw.com for a free legal consultation. More information can also be found on the Arentz Law Group Zyban Birth Defect Help Center page on Facebook.
Contact:
Arentz Law Group
1-800-305-6000
[email protected]
Photo(s):
http://www.prlog.org/12472684
SOURCE Arentz Law Group
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article